"AI Predicts Glioblastoma Survival and Guides Treatment in Groundbreaking Study"

Researchers at King's College London have trained an artificial intelligence system to predict the survival rate of patients with glioblastoma, the most lethal form of brain cancer, following radiotherapy. The AI can determine if patients will live for at least eight months, allowing doctors to explore other treatments if necessary. By analyzing a single MRI scan, the AI can provide the same results as regular scans, potentially eliminating delays in treatment. This development could improve the identification of patients who require early second-line treatment or clinical trial enrollment, ultimately empowering patients to make informed choices about their treatment.